Clinical Trials · NCT03940807

Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis

WithdrawnPhase 3Gonadorelin (Prohibited)
Phase
Phase 3
Recruitment status
Withdrawn
Sponsor
University Hospital, Toulouse
Enrollment
0
Start date
Apr 2022
Locations
14 sites, France
Primary endpoint
Number of live birth after first or second in vitro fertilization (IVF)/intra cytoplasmic sperm injection (ICSI) attempt.
View Gonadorelin compound reference